BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25012837)

  • 1. Vagal and recurrent laryngeal neuropathy following stereotactic ablative radiation therapy in the chest.
    Shultz DB; Trakul N; Maxim PG; Diehn M; Loo BW
    Pract Radiat Oncol; 2014; 4(4):272-8. PubMed ID: 25012837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
    Guckenberger M; Klement RJ; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N; Flentje M
    Radiother Oncol; 2013 Oct; 109(1):13-20. PubMed ID: 24183066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema.
    Binkley MS; Shrager JB; Leung AN; Popat R; Trakul N; Atwood TF; Chaudhuri A; Maxim PG; Diehn M; Loo BW
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):216-23. PubMed ID: 25015205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors.
    Qian Y; Zhu H; Pollom EL; Durkee BY; Chaudhuri AA; Gensheimer MF; Diehn M; Shultz DB; Loo BW
    Pract Radiat Oncol; 2017; 7(6):e525-e529. PubMed ID: 28669706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in radiobiological modeling: can we decide between LQ and LQ-L models based on reviewed clinical NSCLC treatment outcome data?
    Santiago A; Barczyk S; Jelen U; Engenhart-Cabillic R; Wittig A
    Radiat Oncol; 2016 May; 11():67. PubMed ID: 27154064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Fractionation and Dose in a Multivariate Model for Radiation-Induced Chest Wall Pain.
    Din SU; Williams EL; Jackson A; Rosenzweig KE; Wu AJ; Foster A; Yorke ED; Rimner A
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):418-24. PubMed ID: 26254680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of 201 non-small cell lung cancer patients given stereotactic ablative radiation therapy shows local control dependence on dose calculation algorithm.
    Latifi K; Oliver J; Baker R; Dilling TJ; Stevens CW; Kim J; Yue B; Demarco M; Zhang GG; Moros EG; Feygelman V
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1108-13. PubMed ID: 24529716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical experience of high-dose ablative lung radiotherapy: high pre-treatment [18F]fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcome.
    Lee DS; Kim YS; Yoo IeR; Kang YN; Kim SJ; Oh JK; Kim YK; Wang YP; Park JG; Kang JH; Han DH; Ahn MI; Lee KY
    Lung Cancer; 2013 May; 80(2):172-8. PubMed ID: 23489556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dosimetric parameter to limit chest wall toxicity in SABR of NSCLC.
    Jumeau R; Filion É; Bahig H; Vu T; Lambert L; Roberge D; Doucet R; Campeau MP
    Br J Radiol; 2017 Jul; 90(1075):20170196. PubMed ID: 28590814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer.
    Sumodhee S; Bondiau PY; Poudenx M; Cohen C; Naghavi AO; Padovani B; Maneval D; Gal J; Leysalle A; Ghalloussi H; Otto J; Doyen J
    BMC Cancer; 2019 Apr; 19(1):305. PubMed ID: 30943943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy for central lung tumors.
    Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
    J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha/beta ratio for normal lung tissue as estimated from lung cancer patients treated with stereotactic body and conventionally fractionated radiation therapy.
    Scheenstra AE; Rossi MM; Belderbos JS; Damen EM; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):224-8. PubMed ID: 24331668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right-sided vocal cord paralysis following stereotactic body radiation therapy for non-small-cell lung cancer: A case report.
    Kanaoka K; Fukuda S; Inagaki Y; Taniguchi Y; Nakao K; Tamiya A; Matsuda Y; Okishio K
    Thorac Cancer; 2023 Jun; 14(16):1534-1537. PubMed ID: 37060336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal voice outcomes following laryngeal reinnervation via vagus-to-recurrent laryngeal nerve anastomosis after vagal nerve sacrifice: a case series.
    Ward GM; Sauder C; Olson GT; Nuara MJ
    Ann Otol Rhinol Laryngol; 2015 Feb; 124(2):153-7. PubMed ID: 25124840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
    Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer.
    Bongers EM; Haasbeek CJ; Lagerwaard FJ; Slotman BJ; Senan S
    J Thorac Oncol; 2011 Dec; 6(12):2052-7. PubMed ID: 22052227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors.
    Le QT; Loo BW; Ho A; Cotrutz C; Koong AC; Wakelee H; Kee ST; Constantinescu D; Whyte RI; Donington J
    J Thorac Oncol; 2006 Oct; 1(8):802-9. PubMed ID: 17409963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective cohort study of bronchial doses and radiation-induced atelectasis after stereotactic body radiation therapy of lung tumors located close to the bronchial tree.
    Karlsson K; Nyman J; Baumann P; Wersäll P; Drugge N; Gagliardi G; Johansson KA; Persson JO; Rutkowska E; Tullgren O; Lax I
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):590-5. PubMed ID: 24074933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.